OverviewSuggest Edit

NeuroMetrix is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company currently markets products for the detection, diagnosis, and monitoring of diabetic neuropathies such as diabetic peripheral neuropathy and median neuropathy (carpal tunnel syndrome).
TypePublic
Founded1996
HQWaltham, US
Websiteneurometrix.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Dec 2018)42(+3%)
Revenue (FY, 2018)$16.1 M(-5%)
Share Price (Dec 2019)$5 (+5%)

Key People/Management at Neurometrix

Shai N. Gozani

Shai N. Gozani

President, Chief Executive Officer and Director
Thomas T. Higgins

Thomas T. Higgins

Senior Vice President and Chief Financial Officer
Frank McGillin

Frank McGillin

Senior Vice President and Chief Commercial Officer
Michael J. MacDonald

Michael J. MacDonald

Senior Vice President and General Manager, Diagnostics
Show more

Neurometrix Office Locations

Neurometrix has an office in Waltham
Waltham, US (HQ)
62 4th Ave
Show all (1)

Neurometrix Financials and Metrics

Neurometrix Revenue

Embed Graph
View revenue for all periods
Neurometrix's revenue was reported to be $16.09 m in FY, 2018
USD

Revenue (Q3, 2019)

2.1m

Gross profit (Q3, 2019)

1.2m

Gross profit margin (Q3, 2019), %

56.2%

Net income (Q3, 2019)

(1.4m)

EBIT (Q3, 2019)

(1.4m)

Market capitalization (6-Dec-2019)

4.9m

Closing stock price (6-Dec-2019)

5.0

Cash (30-Sept-2019)

3.2m

EV

4.2m
Neurometrix's current market capitalization is $4.9 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

10.4m7.6m5.3m5.5m7.3m12.0m17.1m16.1m

Cost of goods sold

4.7m3.6m2.2m2.6m4.0m7.1m10.2m8.7m

Gross profit

5.7m4.0m3.1m2.9m3.3m4.9m6.9m7.4m

Gross profit Margin, %

55%53%58%53%46%41%40%46%
USDY, 2019

EV/EBIT

-3 x

EV/CFO

-1.2 x

Financial Leverage

2.4 x
Show all financial metrics

Neurometrix Online and Social Media Presence

Embed Graph

Neurometrix News and Updates

NeuroMetrix Reports Q3 2019 Financial Results

WOBURN, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2019.

NeuroMetrix, Inc. Announces Date for Second Quarter 2019 Financial Results Conference Call

WALTHAM, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 second quarter financial results before the opening of the market on Thursday, July 18, 2019. The Company will host a conference call at 8:00 a.m., Eastern Time on July…

NeuroMetrix Reports Q1 2019 Financial Results

WALTHAM, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended March 31, 2019.

NeuroMetrix Reports New Clinical Studies Published on DPNCheck

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of three new DPNCheck® clinical studies. DPNCheck is a point-of-care test that provides accurate and cost-effective screening, diagnosis and monitoring of diabetic peripheral neuropathy (DP…

NeuroMetrix Reports Q4 and Full Year 2018 Financial Results

WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter and year ended December 31, 2018.

NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain

WALTHAM, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of results from a randomized controlled trial of Quell® in subjects with chronic low back pain in the journal Pain Practice.  The paper is titled “Outcome of a High Frequency Transcutaneous…
Show more

Neurometrix Frequently Asked Questions

  • When was Neurometrix founded?

    Neurometrix was founded in 1996.

  • Who are Neurometrix key executives?

    Neurometrix's key executives are Shai N. Gozani, Thomas T. Higgins and Frank McGillin.

  • How many employees does Neurometrix have?

    Neurometrix has 42 employees.

  • What is Neurometrix revenue?

    Latest Neurometrix annual revenue is $16.1 m.

  • What is Neurometrix revenue per employee?

    Latest Neurometrix revenue per employee is $383.1 k.

  • Who are Neurometrix competitors?

    Competitors of Neurometrix include Biop Medical, Cantel Medical and bioMerieux.

  • Where is Neurometrix headquarters?

    Neurometrix headquarters is located at 62 4th Ave, Waltham.

  • Where are Neurometrix offices?

    Neurometrix has an office in Waltham.

  • How many offices does Neurometrix have?

    Neurometrix has 1 office.